This could be explained by the fact that higher PSMA expression in prostate cancer tumor cells occur in patients submitted to antihormonal treatment (8, 13, 14) who are usually older, with a higher comorbidity burden and hence for whom surgery is not indicated (15). This evidence concerns the gene FOLH1 and neoplasm.